课题基金 / 基金详情

Mesenchymal Stem Cells in Chronic Lung Disease of Prematurity: Culprit or Savior?

Mesenchymal Stem Cells in Chronic Lung Disease of Prematurity: Culprit or Savior?
间充质干细胞治疗早产儿慢性肺病：罪魁祸首还是救世主？
批准号：
269884
负责人：
Collins Jennifer J
金额：
$9.83万
依托单位：
Ottawa Hospital Research Institute
依托单位国家：
加拿大
项目类别：
Fellowship Programs
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=269884&lang=en
关键词：
Bronchopulmonary Dysplasia Differentiation Assays Flow Cytometry Lung Development Mesenchymal Stem Cells Oxygen Injury Primary Cell Culture Rat/ Baboon Model For Bpd Stretch Injury Transforming Growth Factor Beta

项目摘要

项目成果

Collins Jennifer J的其他基金

相关文献

中文摘要
翻译
在加拿大，8%的婴儿早产，年龄在24到37周之间。最常见的并发症之一是支气管肺发育不良(BPD)。大多数早产儿需要机械通气和补充氧气
英文摘要
In Canada 8% of all babies are born preterm, between 24 and 37 weeks of gestational age. One of the most common complications seen in these children is bronchopulmonary dysplasia (BPD). Most preterm infants need mechanical ventilation and supplemental oxy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Altered Repair Potential And Gene Expression Profile Of CD146+ Endogenous Lung Mesenchymal Stromal Cells in Experimental Bronchopulmonary Dysplasia